 |
 |
 |
 |
 |
 |
 |
|
|
Roundtable: Cancer Care – Cost, Access, and ValueA presentation from the NCCN 12th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida, on March 16, 2007 Presenters Moderator: Clifford Goodman, PhD Peter B. Bach, MD, MAPP Joseph S. Bailes, MD Schumarry H. Chao, MD, MBA Peter Juhn, MD, MPH Lee Newcomer, MD, MHA Deborah Schrag, MD, MPH Jayson S. Slotnik, JD, MPH Mary Lou Smith, JD, MBA Margaret A. Tempero, MD Sean Tunis, MD, MSc Faculty Disclosure Statements All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. The speakers listed below have disclosed that they have no financial interests, arrangements, or affiliations with the manufacturer of any products or devices to be discussed in this activity or who may financially support the activity: Peter B. Bach, MD, MAPP The speakers listed below have disclosed that they have financial interests, arrangements, or affiliations with the manufacturer of any products or devices to be discussed in this activity or who may financially support the activity: Schumarry H. Chao, MD, MBA Clifford Goodman, PhD Lee Newcomer, MD, MHA Mary Lou Smith, JD, MBA Margaret A. Tempero, MD Sean Tunis, MD, MSc All speakers have indicated that their presentations will not include discussion of investigational or unlabeled uses of commercial products. Program Overview Our nation's biomedical research enterprise is delivering a broad array of innovative and promising drugs, biologics, devices, and procedures. While these technologies bode well for improved effectiveness and quality in cancer care, the introduction of these technologies also portends significant increases in the cost of managing patients with cancer. The NCCN Roundtable: Cancer Care – Cost, Access, and Value will discuss the ability of our country to offer availability and access to new advances while absorbing the increased costs associated with them. Thought leaders from interested constituencies will provide their perspectives on this issue that is so important to those living with cancer. Educational Objectives Following this activity, participants should be able to:
Intended Audience This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer. Activity Instructions Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation. Participants should review the learning objectives and faculty disclosure statement prior to listening to a presentation in its entirety. You must be connected to the Internet in order to review and complete the evaluation form. A statement of credit will be electronically generated once you complete the evaluation form. To receive credit, this activity must be completed no later than August 29, 2008. There is no fee for participating in this activity. Accreditation Information Physicians The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians. NCCN designates this educational activity for a maximum of 1.25 AMA PRA Category Nurses This activity is approved for 1.2 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product. Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity. Release date: July 10, 2007
|
|
NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™ |
|
|
